Doxylamine Succinate en es it fr

Doxylamine Succinate Brand names, Doxylamine Succinate Analogs

Doxylamine Succinate Brand Names Mixture

  • No information avaliable

Doxylamine Succinate Chemical_Formula

C9H23INO3PS

Doxylamine Succinate RX_link

http://www.rxlist.com/cgi/generic2/phospholine.htm

Doxylamine Succinate fda sheet

Doxylamine Succinate msds (material safety sheet)

Doxylamine Succinate Synthesis Reference

No information avaliable

Doxylamine Succinate Molecular Weight

383.228 g/mol

Doxylamine Succinate Melting Point

138 oC

Doxylamine Succinate H2O Solubility

Soluble

Doxylamine Succinate State

Solid

Doxylamine Succinate LogP

-2.25

Doxylamine Succinate Dosage Forms

Ophthalmic solution (eye drops)

Doxylamine Succinate Indication

For use in the treatment of subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.

Doxylamine Succinate Pharmacology

Echothiophate Iodide is a potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma. Echothiophate iodide will depress both plasma and erythrocyte cholinesterase levels in most patients after a few weeks of eyedrop therapy.

Doxylamine Succinate Absorption

No information avaliable

Doxylamine Succinate side effects and Toxicity

Side effects include blurred vision or change in near or distant vision and eye pain.

Doxylamine Succinate Patient Information

No information avaliable

Doxylamine Succinate Organisms Affected

Humans and other mammals